Tandy J. Warnow Department of Computer Science University of Arizona Tucson AZ USA email: tandy cs, arizona, edu Abstract In an earlier paper, we described a new method for phylogenetic tree reconstruction called the Disk Covering Method, or DCM. This is a general method which can be used with an)' existing phylogenetic method in order to improve its performance, lCre showed analytically and experimentally that when DCM is used in conjunction with polynomial time distance-based methods, it improves the accuracy of the trees reconstructed. In this paper, we discuss a variant on DCM, that we call DCM2. DCM2 is designed to be used with phylogenetic methods whose objective is the solution of NPhard optimization problems. We also motivate the need for solutions to NPhard optimization problems by showing that on some very large and important datasets, the most popular (and presumably best performing) polynomial time distance methods have poor accuracy. Introduction 118 HUSON The accurate recovery of the phylogenetic branching order from molecular sequence data is fundamental to many problems in biology. Multiple sequence alignment, gene function prediction, protein structure, and drug design all depend on phylogenetic inference. Although many methods exist for the inference of phylogenetic trees, biologists who specialize in systematics typically compute Maximum Parsimony (MP) or Maximum Likelihood (ML) trees because they are thought to be the best predictors of accurate branching order. Unfortunately, MP and ML optimization problems are NPhard, and typical heuristics use hill-climbing techniques to search through an exponentially large space. When large numbers of taxa are involved, the computational cost of MP and ML methods is so great that it may take years of computation for a local minimum to be obtained on a single dataset (Chase et al. 1993; Rice, Donoghue, & Olmstead 1997). It is because of this computational cost that many biologists resort to distance-based calculations, such as Neighbor-Joining (NJ) (Saitou & Nei 1987), even though these may poor accuracy when the diameter of the tree is large (Huson et al. 1998). As DNA sequencing methods advance, large, divergent, biological datasets are becoming commonplace. For example, the February, 1999 issue of Molecular Biology and Evolution contained five distinct datascts of more than 50 taxa, and two others that had been pruned below that.
IBM Watson Health has formed a medical imaging collaborative with more than 15 leading healthcare organizations. The goal: To take on some of the most deadly diseases. The collaborative, which includes health systems, academic medical centers, ambulatory radiology providers and imaging technology companies, aims to help doctors address breast, lung, and other cancers; diabetes; eye health; brain disease; and heart disease and related conditions, such as stroke. Watson will mine insights from what IBM calls previously invisible unstructured imaging data and combine it with a broad variety of data from other sources, such as data from electronic health records, radiology and pathology reports, lab results, doctors' progress notes, medical journals, clinical care guidelines and published outcomes studies. As the work of the collaborative evolves, Watson's rationale and insights will evolve, informed by the latest combined thinking of the participating organizations.
Researchers at the University of Washington have devised a new app for smart speakers like Amazon's Echo to help parents monitor their baby's breathing. Called BreathJunior, the experimental app will be able to measure the rate of a baby's breathing and detect symptoms of sleep apnea. The team initially conducted a test of the device with five babies in the neonatal intensive care unit at a hospital in Washington. BreathJunior (pictured above) is an experimental app that monitors a baby's breathing using a smart speaker According to a report from MIT Tech Review, the team plans to eventually release the app as a commercial product via the company Sound Life Sciences. But first, they'll present the results of the trial at the upcoming MobiCom, a yearly conference on mobile computing in Los Cabos, Mexico.
Normative expert systems have not become commonplace because they have been difficult to build and use. Over the past decade, however, researchers have developed the influence diagram, a graphical representation of a decision maker's beliefs, alternatives, and preferences that serves as the knowledge base of a normative expert system. Most people who have seen the representation find it intuitive and easy to use. Consequently, the influence diagram has overcome significantly the barriers to constructing normative expert systems. Nevertheless, building influence diagrams is not practical for extremely large and complex domains. In this book, I address the difficulties associated with the construction of the probabilistic portion of an influence diagram, called a knowledge map, belief network, or Bayesian network. I introduce two representations that facilitate the generation of large knowledge maps. In particular, I introduce the similarity network, a tool for building the network structure of a knowledge map, and the partition, a tool for assessing the probabilities associated with a knowledge map. I then use these representations to build Pathfinder, a large normative expert system for the diagnosis of lymph-node diseases (the domain contains over 60 diseases and over 100 disease findings). In an early version of the system, I encoded the knowledge of the expert using an erroneous assumption that all disease findings were independent, given each disease. When the expert and I attempted to build a more accurate knowledge map for the domain that would capture the dependencies among the disease findings, we failed. Using a similarity network, however, we built the knowledge-map structure for the entire domain in approximately 40 hours. Furthermore, the partition representation reduced the number of probability assessments required by the expert from 75,000 to 14,000.
Health care executives from IBM Watson and Athenahealth athn debated that question onstage at Fortune's inaugural Brainstorm Health conference Tuesday. In addition to partnering with Celgene celg to better track negative drug side effects, IBM ibm is applying its cognitive computing AI technology to recommend cancer treatment in rural areas in the U.S., India, and China, where there is a dearth of oncologists, said Deborah DiSanzo, general manager for IBM Watson Health. For example, IBM Watson could read a patient's electronic medical record, analyze imagery of the cancer, and even look at gene sequencing of the tumor to figure out the optimal treatment plan for a particular person, she said. "That is the promise of AI--not that we are going to replace people, not that we're going to replace doctors, but that we really augment the intelligence and help," DiSanzo said. Athenahealth CEO Jonathan Bush, however, disagreed.